Article

Weekly Webinar Series Part 6: Managing Lung Cancer Patients Through the COVID-19 Pandemic

Author(s):

In part 6 of our weekly COVID-19 Webinar Series, our panel of experts will share the latest updates and insights on the novel coronavirus. Join us Wednesday, April 29, 2020 at 8 PM EST.

Date/Time: Wednesday, April 29, 2020 at 8 PM EDT

In part 6 of our weekly COVID-19 Webinar Series, Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; H. Jack West, MD: and special guest speaker, Brendon Stiles, MD; will share the latest updates and insights on the novel coronavirus.

Click here to register today!

Speakers:

Associate Professor; Director, Lung Cancer, Medical Oncology Program at Cleveland Clinic, Cleveland, Ohio

Associate Professor of Medicine; Director, Thoracic Oncology at Georgetown University, Washington, DC

Leslye M. Heisler Assistant; Professor of Medicine at University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania

Associate Clinical Professor in Medical Oncology; Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, Irwindale, CA

Brendon Stiles, MD, Special Guest Speaker; Associate Professor of Cardiothoracic Surgery, Weill Cornell Medical College and Associate Attending Cardiothoracic Surgeon at NewYork-Presbyterian Hospital

Related Videos
Alec Watson, MD
Balazs Halmos, MD
Balazs Halmos, MD
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of pathologists in molecular testing in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of RNA and other testing considerations for detecting NRG1 and other fusions in solid tumors.
Mary B. Beasley, MD, discusses the prevalence of NRG1 fusions in non–small cell lung cancer and pancreatic cancer.